Users who have achieved significant results may choose to continue at a maintenance dose, take a break and reassess, or adjust their protocol in consultation with a healthcare provider
Given the heterogeneous follow-up duration and absence of standardized assessment windows, glycemic findings should be viewed as descriptive longitudinal observations rather than definitive efficacy estimates
Tirzepatide in the SURMOUNT trials showed even greater results, with some dose groups averaging over 20 percent body weight reduction
Dietary habits and meal composition significantly impact nausea duration
Fermented foods: Yogurt, kimchi, and sauerkraut support gut bacteria that may influence GLP-1 levels
Were moving toward a more holistic and personalized approach to menopause care, says Dr